Only a part is due to the impending disaster when HS leaves. The larger issue revolves around leadership and vision for the future. Forest was late to the big pharma game, but did strike gold with celexa and lexapro. As other large companies wound down their over sized sales force, Forest was just beginning to increase there size. Besides that, the world of pharma is going from huge blockbuster type drugs to smaller, niche like drugs and those aren't my words, but the words of other large company CEO's, like Novartis. Forest underpays, under performs and over hires. The days of quid pro quo drug writing are largely over so there really has to be a benefit to doctor and patient. That benefit has to be so overwhelmingly evident that it overwhelms the large obstacles we all face along with the doctors in getting drugs covered. Forest sells to many "me too" products and in my own opinion, again the market will shift towards drugs geared for specific populations rather than the masses. Even device companies are hitting brick walls as insurance companies opt for physical therapy over surgeries. It's a new landscape and that requires new thinking. I am constantly amazed at how behind much of the leadership at forest is in recognizing and reacting to these trends. My humble advice is to find a niche company, that pays well, and serves a legitimate purpose. A purpose that doctors can't easily shoo away. There aren't tons of these jobs out there, but that's why the title is "If you're talented..." Things will change at Forest. No doubt about it. Those who don't believe just don't want too. All it takes is a look across the industry to see that while we were late to the big pharma party, we are the most top heavy sales force and we are late to adjust to the changing landscape of pharma. Sorry for the novel.